S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

IKT Inhibikase Therapeutics Inc

3.05

0.00 (0.00%)

Pre Market

Last Updated: 20:55:41

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Friday 6 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 6 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 6 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 26 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 24 October 2024 (2 months ago) • Edgar (US Regulatory)

More Inhibikase Therapeutics Inc News Articles

National Australia Bank

Commonwealth Bank Of Aus...

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions